Forte Biosciences, Inc.

Biotechnology • Healthcare • Dallas, TX, United States • FBRX (NCM)

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

310 618 6994 3060 Pegasus Park Drive, Dallas, TX 75247, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat

MarketBeat • Dec 25

Positive week for Forte Biosciences, Inc. (NASDAQ:FBRX) institutional investors who lost 1.7% over the past year - Yahoo Finance

Yahoo Finance • Dec 12

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - marketscreener.com

marketscreener.com • Dec 22

Firm Advises Forte Biosciences on $75 Million Public Offering - Wilson Sonsini

Wilson Sonsini • Jun 25

Forte Biosciences (FBRX) Price Target Increased by 16.98% to 53.30 - Nasdaq

Nasdaq • Sep 30

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Forte Biosciences, Inc. had layoffs?

No layoff events have been recorded for Forte Biosciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Forte Biosciences, Inc. have?

Forte Biosciences, Inc. has approximately 16 employees.

What industry is Forte Biosciences, Inc. in?

Forte Biosciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Forte Biosciences, Inc. a publicly traded company?

Yes, Forte Biosciences, Inc. is publicly traded under the ticker symbol FBRX on the NCM. The company has a market capitalization of approximately $0.35 billion.

Where is Forte Biosciences, Inc. headquartered?

Forte Biosciences, Inc. is headquartered in Dallas, TX, United States at 3060 Pegasus Park Drive, Dallas, TX 75247, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.